As of May 24, 2025, IRadimed Corp (IRMD) reports a Current Ratio of 8.84.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of IRadimed Corp's Current Ratio
Over recent years, IRadimed Corp's Current Ratio has shown a moderate pattern. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 8.84 |
| 2023-12-31 | 4.65 |
| 2022-12-31 | 9.06 |
| 2021-12-31 | 11.18 |
| 2020-12-31 | 12.96 |
This slight downward trend highlights how IRadimed Corp manages its short-term assets and liabilities over time.
Comparing IRadimed Corp's Current Ratio to Peers
To better understand IRadimed Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| IRadimed Corp (IRMD) | 8.84 |
| Second Sight Medical Products Inc (EYES) | 28.64 |
| Rewalk Robotics Ltd (RWLK) | 15.17 |
| Delcath Systems Inc (DCTH) | 12.01 |
| Soliton Inc (SOLY) | 11.44 |
| Profound Medical Corp (PRN.TO) | 10.52 |
Compared to its competitors, IRadimed Corp's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.